Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000078003-25-000150
Filing Date
2025-11-04
Accepted
2025-11-04 07:03:48
Documents
95
Period of Report
2025-09-28

Document Format Files

Seq Description Document Type Size
1 10-Q pfe-20250928.htm   iXBRL 10-Q 2892178
2 EX-31.1 pfe-exh311x9282025x10q.htm EX-31.1 8964
3 EX-31.2 pfe-exh312x9282025x10q.htm EX-31.2 8956
4 EX-32.1 pfe-exh321x9282025x10q.htm EX-32.1 4473
5 EX-32.2 pfe-exh322x9282025x10q.htm EX-32.2 4454
  Complete submission text file 0000078003-25-000150.txt   14742302

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20250928.xsd EX-101.SCH 85503
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20250928_cal.xml EX-101.CAL 158715
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20250928_def.xml EX-101.DEF 438108
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20250928_lab.xml EX-101.LAB 916494
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20250928_pre.xml EX-101.PRE 675212
98 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20250928_htm.xml XML 3123363
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-03619 | Film No.: 251446395
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)